Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- Check3 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a change in the site release rather than the underlying study information.SummaryDifference0.0%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check18 days agoChange DetectedNo additions or deletions were detected; the page content appears unchanged.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be an internal versioning change and does not alter study data or user-facing content.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 on the page.SummaryDifference0.0%

- Check61 days agoChange DetectedNo additions or deletions were detected on the page; the study details and related sections appear unchanged.SummaryDifference0.0%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.